Registration

VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
—
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

LobbyistCovered position, as disclosed
EUSTACIA LEE REIDY New N/A
AMIT K SACHDEV New HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL;

Health Issues HCR

Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

LobbyistCovered position, as disclosed
EUSTACIA LEE REIDY New N/A
AMIT K SACHDEV New HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL;

Medicare/Medicaid MMM

Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

LobbyistCovered position, as disclosed
EUSTACIA LEE REIDY New N/A
AMIT K SACHDEV New HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL;

Budget/Appropriations BUD

Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

LobbyistCovered position, as disclosed
EUSTACIA LEE REIDY New N/A
AMIT K SACHDEV New HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL;

Medical/Disease Research/Clinical Labs MED

Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

LobbyistCovered position, as disclosed
EUSTACIA LEE REIDY New N/A
AMIT K SACHDEV New HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL;

Science/Technology SCI

Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.

LobbyistCovered position, as disclosed
EUSTACIA LEE REIDY New N/A
AMIT K SACHDEV New HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL;

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.